These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34156675)

  • 1. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
    Liu DK; Yu S; Li JP; Song WW; Li JH
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
    Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G
    Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 6. Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1.
    Zhang W; Hong W
    Cancer Biother Radiopharm; 2024 Mar; 39(2):153-163. PubMed ID: 33052706
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
    Li WJ; Li G; Liu ZW; Chen ZY; Pu R
    Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
    Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
    Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.
    Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y
    J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
    Wang C; Wang Q; Weng Z
    Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXN3 Expression Regulated by miR-299-5p Inhibiting the Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells.
    Maimaitiming K; Yilihamu A; Keyimu K; Keranmu R; Li J; Xu H; Wufuer D
    Protein Pept Lett; 2022; 29(9):788-795. PubMed ID: 35975858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).
    Wang H; Jiang Z; Chen H; Wu X; Xiang J; Peng J
    Med Sci Monit; 2017 Feb; 23():640-648. PubMed ID: 28159956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma.
    Zhang Y; Zhang Z; Huang W; Zeng J
    J Cell Physiol; 2020 Nov; 235(11):8035-8047. PubMed ID: 31970774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.